On July 24, Indian equity benchmarks closed in the red. The BSE Sensex slipped 542.47 points or 0.66% to end at 82,184.17, while the Nifty 50 declined by 157.80 points or 0.63%, settling at 25,062.10.
As of 8:20 AM on July 25, GIFT Nifty futures were trading 18 points higher at 24,986, indicating a slightly positive start for the day.
Let’s look at the key stocks that could influence markets on July 25, 2025:
Adani Enterprises, the flagship firm of the Adani Group has entered into a 50:50 joint venture with MetTube Mauritius in the copper tubes segment. The agreement involves a stake swap between Adani's subsidiaries KCTL and MCIPL reflecting strategic expansion into high-demand industrial sectors.
State-run REC Ltd reported a strong Q1, with net profit rising 29% YoY to ₹4,465 crore, driven by a 37.6% surge in Net Interest Income (NII) to ₹5,666 crore. The board also declared an interim dividend of ₹4.60 per share for FY26.
Wipro secured a multi-year deal to modernise National Grid SA’s meter data infrastructure in Saudi Arabia. The engagement involves deploying a smart meter data management system across the transmission network.
Surat-based Aether Industries posted a 57% YoY jump in Q1 net profit to ₹47 crore, with revenue up 42.2% at ₹256.1 crore, reflecting strong demand and operating leverage.
Phoenix Mills reported a modest 3.4% YoY rise in Q1 net profit to ₹240.6 crore and 4.5% growth in revenue at ₹984.5 crore. The board approved the acquisition of CPP Investments' 49% stake in ISMDPL.
India’s premier electricity trading platform IEX reported a 25.2% YoY growth in Q1 profit to ₹120.7 crore. Revenue increased 14.7% to ₹141.7 crore, driven by consistent volumes and demand for power trading.
Navratna defence PSU BEL bagged fresh defence orders worth ₹563 crore since June 30, including systems for maritime awareness, navigation, and secure communications highlighting continued government spending on defence modernisation.
GR Infraprojects emerged as the lowest bidder for a ₹290.23 crore EPC project to construct a 26.67-km bypass in Jharkhand. The project comes with a 24-month execution timeline and adds to the company's strong order book.
Sun Pharma’s US subsidiaries SPII and Taro have agreed to a $200 million settlement in an antitrust lawsuit related to generic drug pricing. The agreement secures a complete release from all end purchaser claims.
With Q1 FY26 earnings in focus, markets are witnessing stock-specific action driven by financial results, strategic developments, and corporate announcements. As more companies report their numbers, investor sentiment is likely to remain aligned with individual performance and outlook rather than broad sectoral trends.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 25, 2025, 8:37 AM IST
Neha Dubey
Neha Dubey is a Content Analyst with 3 years of experience in financial journalism, having written for a leading newswire agency and multiple newspapers. At Angel One, she creates daily content on finance and the economy. Neha holds a degree in Economics and a Master’s in Journalism.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
